LUNG NON-SMALL CELL CARCINOMA

This study tested a special smoking cessation program (ETIP) in 19 adults with head and neck or lung cancer. The program combined counseling, medication, and nicotine replacement to help patients cut down or quit smoking. Researchers also checked if reducing smoking changed the t…

This early-phase study tested a vaccine called CIMAvax-EGF in 20 people at high risk for lung cancer or survivors at risk of recurrence. The vaccine works by helping the body make antibodies against a protein that can fuel cancer growth. Researchers checked safety, immune respons…

This study tested whether the immunotherapy drug pembrolizumab can prevent lung cancer from growing in people with early-stage non-small cell lung cancer or high-risk lung nodules. 45 participants received the drug and were monitored for tumor response and survival. The goal was …

This study watched conversations between 37 lung cancer patients and their doctors to create a decision aid. The tool helps patients who have had surgery decide whether to have extra treatment. No drugs were tested; the goal was to improve shared decision-making.

This study looked at 182 older adults with blood cancer or lung cancer to see if a special calculator could predict who would have severe side effects from chemotherapy. Researchers measured patients' overall wellness before and after treatment. The goal is to help doctors choose…